Roivant Sciences Ltd. (ROIV) Earnings
NASDAQ·Healthcare·Biotechnology
$27.91
+0.22%
Mkt Cap $20.96B
Next Earnings
In 29 daysThu, May 28, 2026
EPS Estimate
-$0.26
2 analysts
Revenue Estimate
$3.41M
Last quarter: beat by +19.88% on EPS, -60.65% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$20.96B
P/E
—
Fwd P/E
—
P/S
2935.98
Rev TTM
—
EPS TTM
-$1.10